DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Omni Shoreham Hotel

2016 年 12 月 05 日 1:00 下午 - 2016 年 12 月 06 日 5:00 下午

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Closing Summary

Session Chair(s)

Chad  Gwaltney, PHD

Chad Gwaltney, PHD

President

Gwaltney Consulting, United States

Closing Summary

Speaker(s)

René  Allard, PHD

Panelist

René Allard, PHD

CTC, Germany

Contractor

J. Jason  Lundy, PHD

Panelist

J. Jason Lundy, PHD

Outcometrix, United States

Principal

David H. Schubert

Panelist

David H. Schubert

United States

Ashley F. Slagle, PHD, MS

Panelist

Ashley F. Slagle, PHD, MS

Aspen Consulting, LLC, United States

Principal, Scientific and Regulatory Consulting

Keith  Wenzel

Panelist

Keith Wenzel

DIA Study Endpoints Community, United States

Volunteer

Elektra  Papadopoulos, MD, MPH

Panelist

Elektra Papadopoulos, MD, MPH

AbbVie, United States

Director, Patient Experience Data and Strategy

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。